Kenvue’s public-market story is entering its final trading phase. The consumer-health company is set to be delisted from the New York Stock Exchange before Monday’s market open, ending the exchange listing for $KVUE after Kimberly-Clark completed its acquisition of Kenvue.

For holders of $KVUE, the central issue is no longer the company’s status as an independent NYSE-listed security. It is the transition created by the completed transaction: settlement, account processing and the resulting share issuance from Kimberly-Clark, whose ticker is $KMB. The delisting report puts the calendar milestone plainly: Kenvue is scheduled to leave the exchange before Monday’s opening bell.

The listing transition matters

Delisting marks the point at which $KVUE will no longer trade on the NYSE as the publicly listed security investors have followed since Kenvue’s standalone market debut. The change follows completion of Kimberly-Clark’s acquisition rather than an ordinary corporate update, making the transaction’s settlement process the key focus for existing holders.

That distinction matters for traders. The familiar $KVUE ticker is set to disappear from NYSE trading, while the completed deal points holders toward shares issued by Kimberly-Clark, $KMB. The available transaction details do not specify an exchange ratio, deal value, closing price or other consideration terms, so the practical takeaway is narrower but important: the securities transition is tied to the completed acquisition and the issuance of Kimberly-Clark shares.

What $KVUE holders are watching

• Exchange status: Kenvue is set to be delisted before Monday’s market open.
• Deal status: The delisting follows completion of Kimberly-Clark’s acquisition of Kenvue.
• Security transition: Kenvue and $KVUE are the company and ticker leaving public exchange trading.
• Post-deal position: The transaction includes resulting share issuance from Kimberly-Clark, traded under $KMB.

The timing compresses the final phase for $KVUE into a clear market event. Before Monday’s open, the NYSE listing is expected to end; after that point, attention shifts from Kenvue’s exchange-traded quote to the completed transaction and the processing of the resulting Kimberly-Clark shares.

A corporate-action finish, not a new trading setup

The acquisition’s completion changes the analytical framework. There is no longer an independent Kenvue listing to evaluate as the transaction reaches its final stage. Instead, holders are navigating the administrative consequences of a completed combination: the end of $KVUE’s NYSE trading and the issuance of $KMB shares associated with the deal.

For market participants, the cleanest signal is the delisting timetable. Kenvue is set to leave the NYSE before Monday’s open, while Kimberly-Clark becomes the listed-company reference point for the resulting ownership position. Until further transaction-specific terms are disclosed, the event is best understood as a completed merger transition with a defined exchange-listing endpoint.